GlassScriptPhysician profile
Sagar Jayesh Pathak
NPI 1700318292
$2,240.54
in general payments reported to CMS, 2019-2025
9 companies · $569 in 2025
The $569 reported for 2025 was more than what 76% of Pediatric Gastroenterology providers received nationally (typical 2025 total: $195).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $24.36 · 2022: $25.29 · 2023: $278 · 2024: $1,344 · 2025: $569.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $1,320 · Food and Beverage: $871.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $1,320.00 |
| Food and Beverage | $870.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Erbe USA INC | $1,320.00 | 2024 | Vio3 Ej2 Hybrid Knife |
| Conmed Corporation | $377.98 | 2023-2025 | Conmed Biliary, Conmed Hemostasis |
| Boston Scientific Corporation | $318.14 | 2023-2025 | Exalt Model D, General - Therapies |
| Fujifilm Healthcare Americas Corporation | $68.83 | 2025 | |
| Abbvie INC. | $53.00 | 2025 | |
| Olympus America INC. | $28.70 | 2025 | Visiglide |
| Sobi, INC | $25.29 | 2022 | |
| Glaxosmithkline, LLC. | $24.36 | 2021 | |
| Alcresta Therapeutics, INC. | $24.24 | 2024 | Relizorb |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sagar Pathak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.